Miravant Medical Technologies Inc.
MRVT
$0.00
$0.000.00%
OTC PK
| 09/30/2005 | 06/30/2005 | 03/31/2005 | 12/31/2004 | 09/30/2004 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -15.73% | -27.66% | -15.89% | 147.42% | -10.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.27% | 36.77% | -17.14% | 63.56% | -17.03% |
| Operating Income | -0.27% | -36.77% | 17.14% | -63.56% | 17.03% |
| Income Before Tax | -1.19% | -31.99% | 32.47% | -107.65% | -392.61% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.19% | -31.99% | 32.47% | -107.65% | -392.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.19% | -31.99% | 32.47% | -107.65% | -392.61% |
| EBIT | -0.27% | -36.77% | 17.14% | -63.56% | 17.03% |
| EBITDA | 0.51% | -38.22% | 16.81% | -69.17% | 15.83% |
| EPS Basic | 4.91% | -17.05% | 50.20% | -46.09% | -305.25% |
| Normalized Basic EPS | 5.83% | -16.31% | 49.92% | 14.61% | 69.13% |
| EPS Diluted | 4.91% | -17.05% | 50.20% | -42.83% | -807.97% |
| Normalized Diluted EPS | 5.83% | -16.31% | 49.92% | 14.61% | 55.13% |
| Average Basic Shares Outstanding | 6.38% | 12.73% | 35.55% | 42.02% | 42.65% |
| Average Diluted Shares Outstanding | 6.38% | 12.73% | 35.55% | 42.02% | -1.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |